Skip to content
Biodatica
Start free

Investigator

Lili Wang

BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · funded by NCI

Companies
1

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$1.3M

Summed across those awards.

First award
Jul 1, 2023

Latest Dec 16, 2024.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Attacking the Tumor Cell-Immune Milieu Interface to Overcome Richter's Transformation

    $632k

    Dec 16, 2024NCIBECKMAN RESEARCH INSTITUTE/CITY OF HOPENIH RePORTER · 11248368 (opens the source filing in a new tab)

  2. R01

    Define the oncogenic role of METTL3 in the pathogenesis of chronic lymphocytic leukemia

    $145k

    Jul 1, 2023NCIBECKMAN RESEARCH INSTITUTE/CITY OF HOPENIH RePORTER · 11127460 (opens the source filing in a new tab)

  3. R01

    Define the oncogenic role of METTL3 in the pathogenesis of chronic lymphocytic leukemia

    $503k

    Jul 1, 2023NCICOLUMBIA UNIVERSITY HEALTH SCIENCESNIH RePORTER · 11526589 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources